Formulation and Evaluation of Fast-Dissolving Oral Film of Rivaroxaban

ABSTRACT

Background:Following the COVID-19 pandemic, microvascular and macrovascular thrombotic problems emerged that required anticoagulants. Rivaroxaban (RN) is a factor Xa inhibitor that treats deep vein thrombosis and the two forms of artery diseases (coronary artery disease and peripheral artery disease). Materials and Methods:The study objective was to create fast-disintegrating rivaroxaban Oral Thin Films (OTF) with the help of various super disintegrants to shorten disintegration time and enhance drug release in order to assist patients who have difficulty in swallowing conventional dosage forms and increase bioavailability. OTF was created using the solvent casting method. A 22 factorial design was employed in Design-Expert® software to develop an ideal formula. Results:The optimized film formula pH, drug content, disintegration time, folding endurance, and dissolution rate were estimated, and the film was subjected to a short-term stability study. The optimized formula exhibited a cumulative drug release of 93.47% in 60 sec. Conclusion:The drug's in vitro release pattern shows first-order kinetics and fickian diffusion was the mechanism of drug release. These findings supported that rivaroxaban OTFs offer a quick release of the medication from the administration site into the systemic circulation.

KEYWORDS

• Rivaroxaban
• Oral thin films
• Factorial design
• Fickian diffusion

Showing references and in-text citations exactly as published.

• DOI10.5530/jyp.2023.15.94Copy

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 15, ISSUE 4Mechanistic Insights into Ipriflavone's Role in Postmenopausal Osteoporosis through Integrated Computational and in vitro TechniquesAnish John, Harsha Ashtekar, Dheeraj Gupta, Pankaj Kumar, Anoop Narayanan V · pp. 629–637Original ArtcileSame type: Article
• Article · VOLUME 15, ISSUE 4Synthetic Identification of New Compounds with Anti-fungal Properties of “1-[3-(2-Hydroxyphenyl)-3-Oxop ropanoyl]- 5,5-Diphenylimidazolidine -2,4-Dione and its Derivatives”Rohit Jaysing Bhor, Shabnam Babu Shaikh, Shirole Rahul Bapusaheb, Satpute Pankaj Bhausaheb, Mahesh Hari Kolhe · pp. 638–648Original ArtcileSame type: Article
• Article · VOLUME 15, ISSUE 4Inhibitory Effects of Lawsone Methyl Ether and Lawsone and their Synergistic Interactions with Acarbose against α-Glucosidase: In silico and in vitro StudiesMuhammad Khan, Muhammad Ajmal Shah, Shabana Bibi, Pharkphoom Panichayupakaranant · pp. 649–658Original ArtcileSame type: Article
• Article · VOLUME 15, ISSUE 4Bioactive Compounds from Momordica charantia, Nigella sativa, and Anethum graveolens against Metabolic Syndrome: Untangling the Complex RelationshipRajashekar S Chavan, Nayeem A. Khatib, Vishal S. Patil · pp. 659–670Original ArtcileSame type: Article